You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Litigation Details for Astellas Pharma Inc. v. Actavis Elizabeth LLC (D. Del. 2016)

✉ Email this page to a colleague

« Back to Dashboard

Astellas Pharma Inc. v. Actavis Elizabeth LLC (D. Del. 2016)

Docket	⤷ Sign Up	Date Filed	2016-10-06
Court	District Court, D. Delaware	Date Terminated	2020-10-05
Cause	35:271 Patent Infringement	Assigned To	Joseph F. Bataillon
Jury Demand	None	Referred To	Christopher J. Burke
Parties	ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.; WINDLAS HEALTHCARE PVT. LTD.
Patents	6,346,532; 6,562,375; 7,342,117; 7,982,049; 8,835,474; RE44,872
Attorneys	Lauren B. Cury; Stephanie Angkadjaja
Firms	Morris, Nichols, Arsht & Tunnell; Phillips, McLaughlin & Hall, P.A.
Link to Docket	External link to docket

Small Molecule Drugs cited in Astellas Pharma Inc. v. Actavis Elizabeth LLC

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Details for Astellas Pharma Inc. v. Actavis Elizabeth LLC (D. Del. 2016)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2016-10-06	1		action for patent infringement of United States Patent Nos. 6,346,532 (“the ’532 patent”), 7,342,117…“Notification of Certification for U.S. Patent Nos. 6,346,532; 6,562,375; 7,342,117; 7,982,049; 8,835,474…7,342,117 (“the ’117 patent”), 7,982,049 (“the ’049 patent”), 8,835,474 (“the ’474 patent”), and RE44,872 (“…validity and patentability of the ’532 patent. A true and correct copy of the ’532 patent is attached …(“the ’872 patent”), arising under the United States patent laws, Title 35, United States Code. This	External link to document
2018-01-22	118		U.S. Patent No. 6,346,532 , U.S. Patent No. 7,342,117, U.S. Patent No. 7,982,049, U.S. Patent No. 8,835,474… U.S. Patent No. 6,346,532, U.S. Patent No. 7,342,117, U.S. Patent No. 7,982,049, U.S. Patent No. 8,…U.S. Patent No. 7,342,117, U.S. Patent No. 7,982,049, U.S. Patent No. 8,835,474 and U.S. Patent No. …U.S. Patent No. 7,342,117, U.S. Patent No. 7,982,049, U.S. Patent No. 8,835,474 and U.S. Patent No. …U.S. Patent No. 7,342,117, U.S. Patent No. 7,982,049, U.S. Patent No. 8,835,474 and U.S. Patent No.	External link to document
2016-12-15	16		U.S. Patent No. 6,346,532; (b) declaring that the claims of U.S. Patent No. 6,346,532 are …infringement of U.S. Patent Nos. 6,346,532 (“the ’532 patent”), 7,342,117 (“the ’117 patent”), 7,982,049 …or more claim of U.S. Patent No. 6,346,532 (“the ’532 patent”) under the Patent Laws of the United States…to be a copy of United States Patent No. 6,346,532 (“the ’532 patent”), which indicates on its face … Paragraph IV certification as to U.S. Patent Nos. 6,346,532; 6,562,375; 7,342,117; 7,982,049; 8,835,474	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.